- Home
- SSY vs ENSC Comparison
SSY vs ENSC Comparison
Compare SSY & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSY
- ENSC
- Stock Information
- Founded
- SSY 1959
- ENSC 2003
- Country
- SSY United States
- ENSC United States
- Employees
- SSY N/A
- ENSC N/A
- Industry
- SSY Hospital/Nursing Management
- ENSC Biotechnology: Pharmaceutical Preparations
- Sector
- SSY Health Care
- ENSC Health Care
- Exchange
- SSY Nasdaq
- ENSC Nasdaq
- Market Cap
- SSY 5.5M
- ENSC 5.5M
- IPO Year
- SSY N/A
- ENSC N/A
- Fundamental
- Price
- SSY $1.00
- ENSC $2.64
- Analyst Decision
- SSY
- ENSC
- Analyst Count
- SSY 0
- ENSC 0
- Target Price
- SSY N/A
- ENSC N/A
- AVG Volume (30 Days)
- SSY 32.0K
- ENSC 24.9K
- Earning Date
- SSY 05-14-2025
- ENSC 05-12-2025
- Dividend Yield
- SSY N/A
- ENSC N/A
- EPS Growth
- SSY N/A
- ENSC N/A
- EPS
- SSY 0.14
- ENSC N/A
- Revenue
- SSY $31,233,000.00
- ENSC $5,210,031.00
- Revenue This Year
- SSY N/A
- ENSC N/A
- Revenue Next Year
- SSY N/A
- ENSC N/A
- P/E Ratio
- SSY $7.25
- ENSC N/A
- Revenue Growth
- SSY N/A
- ENSC 133.58
- 52 Week Low
- SSY $0.53
- ENSC $2.12
- 52 Week High
- SSY $1.91
- ENSC $14.67
- Technical
- Relative Strength Index (RSI)
- SSY 50.27
- ENSC 23.45
- Support Level
- SSY $0.97
- ENSC $3.30
- Resistance Level
- SSY $1.09
- ENSC $3.58
- Average True Range (ATR)
- SSY 0.08
- ENSC 0.32
- MACD
- SSY -0.00
- ENSC -0.05
- Stochastic Oscillator
- SSY 61.54
- ENSC 22.21
About SSY SunLink Health Systems Inc.
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.